These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32163306)

  • 1. Proposals of models for new formulations of the current complication-free cure (P+) and uncomplicated tumor control probability (UTCP) concepts, and total normal tissue complication probability of late complications.
    Frometa-Castillo T; Pyakuryal A; Wals-Zurita A; Mesbahi A
    Int J Radiat Biol; 2020 Jul; 96(7):847-850. PubMed ID: 32163306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the normal tissue non-complication probability (NTCP0) in the safety evaluations as a new alternative of assessing the side-effects of the radiation oncology treatments.
    Frometa-Castillo T; Pyakuryal A; Narayanasamy G; Wals-Zurita A; Mesbahi A
    Int J Radiat Biol; 2023; 99(4):656-662. PubMed ID: 35930494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments.
    Frometa-Castillo T; Pyakuryal A; Narayanasamy G; Mesbahi A; Wals-Zurita A
    Rep Pract Oncol Radiother; 2022; 27(4):602-609. PubMed ID: 36196423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
    Mackay RI; Hendry JH
    Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dose calculation models on radiotherapy outcomes and quality adjusted life years for lung cancer treatment: do we need to measure radiotherapy outcomes to tune the radiobiological parameters of a normal tissue complication probability model?
    Chaikh A; Docquière N; Bondiau PY; Balosso J
    Transl Lung Cancer Res; 2016 Dec; 5(6):673-680. PubMed ID: 28149761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
    Lu JY; Lin PX; Huang BT
    Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to visualize the uncertainty of the prediction of radiobiological models.
    Zhang L; Hub M; Thieke C; Floca RO; Karger CP
    Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SORS: a new software for the simulation of radiotherapy schedule.
    Tamborra P; Simeone G; Carioggia E
    Med Dosim; 2010; 35(3):208-13. PubMed ID: 19931032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stochastic model for the normal tissue complication probability (NTCP) and applicationss.
    Stocks T; Hillen T; Gong J; Burger M
    Math Med Biol; 2017 Dec; 34(4):469-492. PubMed ID: 27591250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
    Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
    J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.
    Sukhikh ES; Sukhikh LG; Taletsky AV; Vertinsky AV; Izhevsky PV; Sheino IN
    Phys Med; 2019 Jun; 62():41-46. PubMed ID: 31153397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).
    Luxton G; Keall PJ; King CR
    Phys Med Biol; 2008 Jan; 53(1):23-36. PubMed ID: 18182685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of radiobiological models as TCP (tumor control probability) and NTCP (normal tissue complication probability): from dose to clinical effects prediction].
    Chaikh A; Thariat J; Thureau S; Tessonnier T; Kammerer E; Fontbonne C; Dubray B; Balosso J; Fontbonne JM
    Cancer Radiother; 2020 Jun; 24(3):247-257. PubMed ID: 32220563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose selection for optimal treatment results and avoidance of complications.
    Nagano H; Nakayama S; Shuto T; Asada H; Inomori S
    Prog Neurol Surg; 2009; 22():11-19. PubMed ID: 18948715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Probabilities of controlling tumors and complications (TCP/NTCP) after radiotherapy: methodologic, physical, and biological aspects].
    Kulik C; Mazurier J; Lartigau E
    Cancer Radiother; 2002 Nov; 6 Suppl 1():155s-165s. PubMed ID: 12587394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
    Song W; Battista J; Van Dyk J
    Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.